Our previous demonstration of an antimetastatic effect of lovastatin, both in rat sarcoma and lymphoma tumor-models, as well as the fact that lovastatin and radiation are able to stop the cell cycle in different phases, suggested the feasibility of a combined treatment. We studied the effect of the in vitro combined treatment of a B-cell rat lymphoma (L-TACB) with lovastatin and irradiation. The results herein obtained provide new information about the role of statins as radiosensitizers. The antitumor effect of the combined treatment was higher than that elicited by either treatment alone. This effect could be a consequence, at least in part, of an enhanced apoptosis
<p>(A) The U87 MG cells were treated with different concentrations of lovastatin for 48 hours, and t...
Lovastatin (an HMG-CoA reductase inhibitor) and troglitazone (a PPAR- gamma agonist) have been inten...
[[abstract]]Lovastatin (an HMG-CoA reductase inhibitor) and troglitazone (a PPAR-gamma agonist) have...
Despite its effectiveness as an antineoplastic drug, doxorubicin (DOX) is usually associated with ca...
The aim of this study was to investigate the protective effect of simvastatin against radiation-indu...
grantor: University of TorontoApoptosis, programmed cell death, is triggered by abrogation...
Introduction:In this study, we investigated the effect of the 3-hydroxy-3-methylgutaryl-CoA reductas...
The HMGCoA reductase inhibitor Lovastatin (LOV) has previously shown to abrogate p21ras farnesylatio...
Both statins and bisphosphonates may inhibit cancer proliferation by two main different mechanisms: ...
Background and Objective: Lovastatin is a HMG-CoA reductase inhibitor and used for the treatment of ...
Abstract Background Ovarian carcinoma is a rarely cur...
Although statins are lipid-lowering drugs that block cholesterol biosynthesis, they exert immunomodu...
The lipid-lowering drugs, statins, induce apoptosis in a variety of tumor cells. Here we investigate...
Both statins and bisphosphonates may inhibit cancer proliferation by two main different mechanisms: ...
AbstractClinical evidence suggests that statins reduce cancer incidence and mortality. However, ther...
<p>(A) The U87 MG cells were treated with different concentrations of lovastatin for 48 hours, and t...
Lovastatin (an HMG-CoA reductase inhibitor) and troglitazone (a PPAR- gamma agonist) have been inten...
[[abstract]]Lovastatin (an HMG-CoA reductase inhibitor) and troglitazone (a PPAR-gamma agonist) have...
Despite its effectiveness as an antineoplastic drug, doxorubicin (DOX) is usually associated with ca...
The aim of this study was to investigate the protective effect of simvastatin against radiation-indu...
grantor: University of TorontoApoptosis, programmed cell death, is triggered by abrogation...
Introduction:In this study, we investigated the effect of the 3-hydroxy-3-methylgutaryl-CoA reductas...
The HMGCoA reductase inhibitor Lovastatin (LOV) has previously shown to abrogate p21ras farnesylatio...
Both statins and bisphosphonates may inhibit cancer proliferation by two main different mechanisms: ...
Background and Objective: Lovastatin is a HMG-CoA reductase inhibitor and used for the treatment of ...
Abstract Background Ovarian carcinoma is a rarely cur...
Although statins are lipid-lowering drugs that block cholesterol biosynthesis, they exert immunomodu...
The lipid-lowering drugs, statins, induce apoptosis in a variety of tumor cells. Here we investigate...
Both statins and bisphosphonates may inhibit cancer proliferation by two main different mechanisms: ...
AbstractClinical evidence suggests that statins reduce cancer incidence and mortality. However, ther...
<p>(A) The U87 MG cells were treated with different concentrations of lovastatin for 48 hours, and t...
Lovastatin (an HMG-CoA reductase inhibitor) and troglitazone (a PPAR- gamma agonist) have been inten...
[[abstract]]Lovastatin (an HMG-CoA reductase inhibitor) and troglitazone (a PPAR-gamma agonist) have...